Biopharma company Population Genetics has raised series B funding from backers including agribusiness firm Syngenta.

Siemens-backed medical device company Sphere Medical is set for an initial public offering, from which it expects to raise $24m.

The Biopharma company will collaborate with existing investor Ipsen to develop new botulinum treatments in a deal that could be worth more than $90m to Syntaxin.

The bank-backed Business Growth Fund's chief executive says its second deal backing of the UK-based travel management company indicates it is "now very much open for business".

Ethernet radio company Siklu has closed its series B round, with support from investors including corporate Qualcomm Ventures.

Intel Capital has provided financing for Turkey-based social commerce startup Grupanya, a daily deals company.

Online wellness marketplace Wahanda has secured $5.5m in a round led by Fidelity Growth Partners Europe.

Corporate venturing unit T-Venture backs the cost estimating company, which was founded six years ago, which acquired an established US company in its sector.

The Business Growth Fund has made its first investment, funding the UK rewards and benefits company Benefex.